Acquisitions. On May 15, 2012, the Company acquired all of the outstanding shares of Apex Systems, Inc., a privately-owned provider of information technology staffing and services headquartered in Richmond, Virginia. The primary reason for the acquisition was to expand the Company's information technology staffing services. The purchase price totaled approximately $610.8 million, comprised of $385.0 million paid in cash at closing, $0.3 million paid in the third quarter related to the net working capital adjustments, and 14.3 million shares of common stock of the Company issued to the holders of shares of common stock and options to purchase common stock of Apex immediately prior to the effective time of the Merger. Acquisition costs related to this transaction totaled approximately $9.4 million and were expensed in 2012. Goodwill is expected to be deductible for tax purposes. The results of operations of Apex have been combined with those of the Company since the acquisition date. Apex revenues and net loss included in the Statement of Operations for the nine months ended September 30, 2012 were $301.2 million and $0.9 million, respectively.

On February 28, 2011, the Company acquired all of the outstanding shares of Valesta, a privately-owned provider of specialized clinical research staffing headquartered in Belgium. The primary reasons for the acquisition were to expand the Life Sciences business operations and to leverage the Company’s infrastructure. The purchase price for Valesta totaled $23.7 million, comprised of $16.8 million in cash paid at closing and potential future earn-out consideration of $6.9 million (the maximum earn-out is capped at a Euro value of 5.0 million or approximately $6.4 million at September 30, 2012 exchange rates) based on estimated financial performance of Valesta through 2013. Acquisition costs totaled approximately $0.4 million and were expensed in 2011. Goodwill is not deductible for tax purposes. The results of operations for the acquisition have been combined with those of the Company since the acquisition date.

On July 31, 2011, the Company acquired all of the outstanding shares of HealthCare Partners (HCP), a privately-owned provider of physician staffing headquartered in Atlanta, Georgia. The primary reasons for the acquisition were to expand the Physician segment business operations geographic coverage and to leverage the Company’s infrastructure. The estimated purchase price for HCP was approximately $19.1 million comprised of $15.7 million in cash paid at closing and potential future earn-out consideration of $3.4 million (the maximum earn-out is capped at $3.7 million) based on estimated financial performance of HCP through 2013. Acquisition costs totaled approximately $57,000 and were expensed in 2011. The Company intends to discontinue the use of the HCP tradename during 2012. Goodwill is deductible for tax purposes. The results of operations for the acquisition have been combined with those of the Company since the acquisition date.

Assets and liabilities of the acquired companies were recorded at their estimated fair values at the dates of acquisition. The excess purchase price over the fair value of net tangible assets and identifiable intangible assets acquired has been allocated to goodwill. The fair value assigned to identifiable intangible assets was determined primarily by using a discounted cash flow method. The Company's allocation of the purchase price for Apex is preliminary, as the valuation of net working capital, pre-acquisition contingencies, income taxes, long-term liabilities, identifiable intangible assets and goodwill are still being finalized. Any material measurement period adjustments will be recorded retrospectively to the acquisition date.

During the quarter ended March 31, 2012, the Company adjusted Valesta's purchase price allocation. The adjustment was to recognize the tax impact of the amortization of identifiable intangible assets. The adjustment was not material and had no impact on the consolidated statement of operations; accordingly it was not presented retrospectively.

During the quarter ended September 30, 2012, the Company adjusted Apex's purchase price allocation. The adjustment was a reduction in the customer relations identifiable intangible asset value and its respective useful life. The adjustment was not material to the consolidated statement of operations; accordingly it was not presented retrospectively.

The fair value of earn-out obligations was based on the present value of the expected future payments to be made to the sellers of the acquired businesses in accordance with the respective purchase agreements. See Note 6 for further information regarding the fair value of earn-outs and the level 3 rollforward disclosure.

The following tables summarize (in thousands) the purchase price allocations for the acquisitions of Apex, which is subject to finalization during the measurement period and HCP and Valesta:



	2012 Acquisition		2011 Acquisitions
	Apex		HCP		Valesta		Total
Current assets	$	169,803	$	3,950	$	6,332	$	10,282
Property and equipment	902		123		299		422
Goodwill	266,716		14,398		17,088		31,486
Identifiable intangible assets	251,555		1,784		5,679		7,463
Other	494		13		26		39
Total assets acquired	$	689,470	$	20,268	$	29,424	$	49,692

Current liabilities	$	77,793	$	1,070	$	4,774	$	5,844
Other	850		49		991		1,040
Total liabilities assumed	78,643		1,119		5,765		6,884
Total purchase price	$	610,827	$	19,149	$	23,659	$	42,808

The following table summarizes (in thousands) the allocation of the purchase price among the identifiable intangible assets for the acquisition of Apex, which is subject to finalization during the measurement period and HCP and Valesta:



		Identifiable Intangible Asset Value
		2012 Acquisition		2011 Acquisitions
	Useful life	Apex		HCP		Valesta		Total
Contractor relations	2 – 5 years	$	10,589	$	814	$	266	$	1,080
Customer relations	2 – 10 years	92,147		950		2,395		3,345
Non-compete agreements	2 – 7 years	2,076		20		440		460
Trademarks	indefinite	146,743		—		2,578		2,578
Total identifiable intangible assets acquired		$	251,555	$	1,784	$	5,679	$	7,463

The summary below (in thousands, except for per share data) presents pro forma consolidated results of operations for the nine months ended September 30, 2012 and 2011 as if the acquisitions of HCP and Valesta occurred on January 1, 2010, and the acquisition of Apex occurred on January 1, 2011. The pro forma financial information gives effect to certain adjustments, including: the amortization of intangible assets and interest expense on acquisition-related debt, changes in the management fees, and increased number of common shares as a result of the acquisition. Acquisition-related costs are assumed to have occurred at the beginning of the year prior to acquisition. The pro-forma financial information is not necessarily indicative of the operating results that would have occurred if the acquisition had been consummated as of the date indicated, nor are they necessarily indicative of future operating results.



	Nine Months Ended
	September 30,
	2012		2011
Revenues	$	1,120,323	$	961,320
Operating income	$	91,319	$	55,040
Net income	$	42,506	$	21,626

Basic earnings per share	$	0.82	$	0.42
Diluted earnings per share	$	0.80	$	0.42

Weighted average number of shares outstanding	51,929		51,170
Weighted average number of shares and dilutive shares outstanding	52,959		52,060